Kidney International

FIGURE 2

FROM:

Systematic review of the impact of N-acetylcysteine on contrast nephropathy

NEESH PANNU, BRADEN MANNS, HELEN LEE and MARCELLO TONELLI

BACK TO ARTICLE

Figure 2.

Figure and tables index
Unfortunately we are unable to provide accessible alternative text for this. If you require assistance to access this image, please contact help@nature.com or the author

Relative risk of contrast nephropathy associated with NAC: All identified trials. Relative risk refers to the risk of contrast nephropathy in the N-acetylcysteine (NAC) group, compared with control. The squares represent the point estimate of relative risk for each study, and their size is proportional to their weight in the pooled estimate of relative risk (represented by the diamond). Bars indicate 95% CI. Q = 26.3, P = 0.02.

Figure and tables index
BACK TO ARTICLE